PMDA — authorised 24 February 2021
- Marketing authorisation holder: Maruho Co., Ltd.
- Status: approved
🇯🇵 Temovate in Japan
PMDA authorised Temovate on 24 February 2021
Marketing authorisation
Temovate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Japan
Frequently asked questions
Is Temovate approved in Japan?
Yes. PMDA authorised it on 24 February 2021.
Who is the marketing authorisation holder for Temovate in Japan?
Maruho Co., Ltd. holds the Japanese marketing authorisation.